Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries (TRYTON)

This study has been completed.
Information provided by (Responsible Party):
Tryton Medical, Inc. Identifier:
First received: December 9, 2010
Last updated: October 17, 2016
Last verified: April 2016